CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 1 filers reported holding CLOVIS ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $31,000 | +34.8% | 26,054 | +104.4% | 0.00% | 0.0% |
| Q2 2022 | $23,000 | -86.1% | 12,745 | -84.5% | 0.00% | -83.3% |
| Q1 2022 | $166,000 | +71.1% | 82,042 | +128.4% | 0.01% | +50.0% |
| Q4 2021 | $97,000 | -47.0% | 35,927 | -6.0% | 0.00% | 0.0% |
| Q4 2020 | $183,000 | +71.0% | 38,200 | +108.5% | 0.00% | +100.0% |
| Q3 2020 | $107,000 | -38.9% | 18,320 | +9.0% | 0.00% | +100.0% |
| Q4 2019 | $175,000 | -58.2% | 16,800 | -40.4% | 0.00% | -75.0% |
| Q2 2019 | $419,000 | +97.6% | 28,173 | +139.0% | 0.00% | +33.3% |
| Q4 2018 | $212,000 | -79.6% | 11,786 | +6.2% | 0.00% | -98.5% |
| Q2 2017 | $1,039,000 | +652.9% | 11,100 | +10.5% | 0.20% | +164.0% |
| Q2 2016 | $138,000 | – | 10,042 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |